We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.35
Bid: 3.30
Ask: 3.40
Change: 0.05 (1.52%)
Spread: 0.10 (3.03%)
Open: 3.30
High: 3.35
Low: 3.30
Prev. Close: 3.30
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

3 Aug 2020 14:49

RNS Number : 9761U
ValiRx PLC
03 August 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Valirx PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Monecor (London) Limited

City and country of registered office (if applicable)

London, UK

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

31/07/2020

6. Date on which issuer notified (DD/MM/YYYY):

03/08/2020

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

6.413

-

6.413

54,062,373

Position of previous notification (if

applicable)

8.86

8.86

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary Shares

GB00BLH13C52

 

3,466,989

-

6.413

-

SUBTOTAL 8. A

3,466,989

6.413

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

London, UK

Date of completion

03/08/2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLUOSORRWUWRAR
Date   Source Headline
28th Sep 20214:41 pmRNSSecond Price Monitoring Extn
28th Sep 20214:36 pmRNSPrice Monitoring Extension
17th Sep 20214:41 pmRNSSecond Price Monitoring Extn
17th Sep 20214:36 pmRNSPrice Monitoring Extension
16th Sep 20217:00 amRNSNew Evaluation Agreement
8th Sep 20217:00 amRNSHolding(s) in Company
7th Sep 20217:00 amRNSHalf-year Report
25th Aug 20217:00 amRNSAppointment of Broker
20th Aug 20212:05 pmRNSSecond Price Monitoring Extn
20th Aug 20212:00 pmRNSPrice Monitoring Extension
6th Jul 20217:00 amRNSPatent update
17th Jun 20214:40 pmRNSSecond Price Monitoring Extn
17th Jun 20214:35 pmRNSPrice Monitoring Extension
27th May 202112:48 pmRNSResult of AGM
27th May 20217:00 amRNSKTH222 Evaluation Agreement Concluded
30th Apr 202112:00 pmRNSPosting of Annual Report and Notice of AGM
27th Apr 20217:00 amRNSFinal Results
1st Mar 20217:00 amRNSTotal Voting Rights
25th Feb 20217:00 amRNSBlock listing Interim Review
18th Feb 20213:39 pmRNSDirector/PDMR Shareholding
15th Feb 20217:00 amRNSExtension of Collaboration Agreement
19th Jan 202111:36 amRNSDirector Disclosure
19th Jan 20217:00 amRNSPatent Status Update
30th Nov 202011:04 amRNSHolding(s) in Company
30th Nov 20207:46 amRNSVAL201 Clinical Trial Full Data Results
10th Nov 20207:00 amRNSAgreement with Kalos Therapeutics
2nd Nov 20207:00 amRNSTotal Voting Rights and Block Listing Update
16th Oct 202011:05 amRNSSecond Price Monitoring Extn
16th Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20204:00 pmRNSExercise of Warrant
1st Oct 20207:00 amRNSTotal Voting Rights and Block Listing Update
30th Sep 202010:34 amRNSHolding(s) in Company
29th Sep 20204:13 pmRNSHolding(s) in Company
29th Sep 20207:00 amRNSExercise of Warrant
28th Sep 20204:41 pmRNSSecond Price Monitoring Extn
28th Sep 20204:35 pmRNSPrice Monitoring Extension
28th Sep 20207:00 amRNSVAL201 Clinical Trial Update
25th Sep 20204:41 pmRNSSecond Price Monitoring Extn
25th Sep 20204:36 pmRNSPrice Monitoring Extension
25th Sep 202011:55 amRNSHolding(s) in Company
24th Sep 202011:05 amRNSSecond Price Monitoring Extn
24th Sep 202011:00 amRNSPrice Monitoring Extension
23rd Sep 202012:39 pmRNSHolding(s) in Company
23rd Sep 20207:06 amRNSSecond Price Monitoring Extn
23rd Sep 20207:04 amRNSPrice Monitoring Extension
23rd Sep 20207:00 amRNSShare Price Movement / Exercise of Warrant
22nd Sep 20204:40 pmRNSSecond Price Monitoring Extn
22nd Sep 20204:36 pmRNSPrice Monitoring Extension
14th Sep 20207:00 amRNSExercise of Warrants and Warrant Update
9th Sep 20206:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.